Sarepta Therapeutics Inc’s filing revealed that its Director Boor Kathryn Jean unloaded Company’s shares for reported $93550.0 on Mar 11 ’24. In the deal valued at $122.93 per share,761 shares were sold. As a result of this transaction, Boor Kathryn Jean now holds 7,516 shares worth roughly $0.95 million.
Then, Wigzell Hans Lennart Rudolf sold 15,000 shares, generating $1,848,795 in total proceeds. Upon selling the shares at $123.25, the Director now owns 22,840 shares.
Before that, Mayo Stephen sold 3,135 shares. Sarepta Therapeutics Inc shares valued at $385,480 were divested by the Director at a price of $122.96 per share. As a result of the transaction, Mayo Stephen now holds 6,621 shares, worth roughly $0.84 million.
BMO Capital Markets initiated its Sarepta Therapeutics Inc [SRPT] rating to an Outperform in a research note published on January 31, 2024; the price target was $170. Deutsche Bank began covering SRPT with “Buy” recommendation on December 12, 2023. Wedbush started covering the stock on November 21, 2023. It rated SRPT as “an Outperform”.
Price Performance Review of SRPT
On Monday, Sarepta Therapeutics Inc [NASDAQ:SRPT] saw its stock jump 0.25% to $126.39. Over the last five days, the stock has lost -1.57%. Sarepta Therapeutics Inc shares have risen nearly 31.07% since the year began. Nevertheless, the stocks have fallen -8.80% over the past one year. While a 52-week high of $159.89 was reached on 02/16/24, a 52-week low of $55.25 was recorded on 01/05/24. SMA at 50 days reached $126.59, while 200 days put it at $110.94. A total of 0.56 million shares were traded, compared to the trading of 0.85 million shares in the previous session.
Levels Of Support And Resistance For SRPT Stock
The 24-hour chart illustrates a support level at 124.95, which if violated will result in even more drops to 123.50. On the upside, there is a resistance level at 127.26. A further resistance level may holdings at 128.12. The Relative Strength Index (RSI) on the 14-day chart is 50.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.05%. Stochastics %K at 43.42% indicates the stock is a holding.
How much short interest is there in Sarepta Therapeutics Inc?
A steep rise in short interest was recorded in Sarepta Therapeutics Inc stocks on Mar 15, 2024, growing by 0.16 million shares to a total of 4.97 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 4.81 million shares. There was a rise of 3.22%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 5.52% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.69.
